Medicover AB (LTS:0RPS) Tariff Resilience Score: 6/10 (As of Jul. 12, 2026)


LTS:0RPS Medicover AB LTS:0RPS
90 GF Score
Price kr230.00
GF Value kr234.91
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Tariff Resilience Score?

Medicover AB LTS:0RPS -0.22% 90 Tariff Resilience Score is 6 as of Jul. 12, 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 90/100 and a GF Value™ of kr234.91 (Fairly Valued). The stock has 5 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Medicover AB ranks better than 83.63% on this metric.

Medicover AB has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Medicover AB has Medicover operates in Europe with some exposure to international supply chains. While tariffs could affect imported medical equipment costs, the company has a strong local supplier network and moderate pricing power. Historical impacts have been limited, and the healthcare sector has some tariff protections.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Medicover AB might have Average Resilient.


Medicover AB  (LTS:0RPS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Medicover AB Tariff Resilience Score Related Terms


LTS:0RPS vs HCA, THC, DVA: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, Medicover AB's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Medicover AB's Tariff Resilience Score falls into.


LTS:0RPS
90GF Score
Medicover AB LTS:0RPS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Medicover AB (LTS:0RPS) has a Tariff Resilience Score of 6 as of Jul. 12, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Medicover AB ranks #110 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 16.4%.
Is Medicover AB's Tariff Resilience Score too high?
Medicover AB's current Tariff Resilience Score is 6. Based on the distribution chart, Medicover AB ranks #110 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medicover AB has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Tariff Resilience Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #110 out of 672 companies for Tariff Resilience Score. This places Medicover AB in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Medicover AB's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr234.91, compared to a current price of kr230.00 — trading 2.1% below its estimated fair value. The current Tariff Resilience Score is 6. Medicover AB's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Tariff Resilience Score is 6 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued. The current stock price of kr230.00 is trading 2.1% below its estimated GF Value™ of kr234.91. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Tariff Resilience Score: 6
  • GF Value™: kr234.91 vs. price of kr230.00 (2.1% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
90GF Score

Get the complete analysis for LTS:0RPS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr230.00
Price
kr234.91
GF Value